What happened Addex Therapeutics Ltd. (NASDAQ: ADXN) said Neurosterix completed Phase 1 studies of N

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, October 8, 2026 - Addex Therapeutic

Jean-Philippe Rocher Appointed Head of Pharmaceutical Development Mikhail Kalinichev, Head of Transl

Addex Therapeutics (NASDAQ: ADXN) reported a CHF 1.1 million operating loss for the first half of 20

Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 27.1% to $0.31 during Monday's after-ma

Addex Therapeutics Ltd (ADXN) Q2 2026 Earnings Call Transcript

Addex Therapeutics (NASDAQ:ADXN) released second-quarter financial results and hosted an earnings ca

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.16) per share. This is a 25.52 per

Companies Reporting Before The Bell • Kandi Technologies Gr (NASDAQ:KNDI) is likely to report earnin

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.52) per share. This is a 47.59 per

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 28, 2026 - Addex Therapeut

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 25, 2026 - Addex Therapeut

Geneva, Switzerland, September 24, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stag

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 26, 2026 - Addex Therapeutics

Gainers Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 142.1% to $13.0 during Monday's

Gainers Innovative Eyewear (NASDAQ:LUCY) stock rose 63.6% to $1.12 during Monday's regular sess

Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session

Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday&#3

Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday&#

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-mark

Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Transcript

Addex Therapeutics (NASDAQ:ADXN) reported first-quarter financial results on Thursday. The transcrip

Companies Reporting Before The Bell • TD Synnex (NYSE:SNX) is projected to report quarterly earnings

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.53) per share. This is a 15.04 per

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 25, 2026 - Addex Therapeutics (

Geneva, Switzerland, June 22, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage bio

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 5, 2026 - Addex Therapeutics (S

Addex Therapeutics Ltd (ADXN) Q4 2025 Earnings Call Transcript

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.50) per share. This is a 9.49 perc

GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive a

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2026 - Addex Therapeutics

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 21, 2026 - Addex Therapeutics

Addex Therapeutics Ltd. Sponsored ADR (NASDAQ: ADXN - Get Free Report) saw a large decrease in short

Addex Therapeutics Ltd. Sponsored ADR (NASDAQ: ADXN - Get Free Report) was the target of a large gro

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, January 7, 2026 - Addex Therapeutic

Up to $3,300,000American Depositary Shares Representing Ordinary Shares​We have entered into an At T

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.50) per share. This is a 45.85 per